BMRN
$BMRN
BioMarin Pharmaceutical Inc.
Rare disease biotech company with gene therapy and enzyme replacement treatments.
Healthcare$54.69
-0.33 (-0.60%)
Day Range$54.26 - $55.62
Prev Close$55.02
Analyst Rating
Strong Buy
27 Buy / 7 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
BMRN: Pipeline Recovery & Valuation Upside
BioMarin ($BMRN) trades at $55.83 with a strong buy consensus and a mean analyst target near $88.9. Forward P/E and PEG point to material upside if pipeline and guidance trends improve.
Apr 6, 2026